A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Apremilast D5 | CAS 1258597-47-5 - Request Quote

Picture of Apremilast D5

Apremilast D5

SZ CAT No:SZ-A051D01
CAS No
1258597-47-5
Mol.F.
C22H19D5N2O7S
Mol.Wt.
465.5
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Apremilast D5 is chemically (S)-N-(2-(1-(3-(Ethoxy-d5)-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide. Apremilast D5 is supplied with detailed characterization data compliant with regulatory guideline. Apremilast D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apremilast.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1258597-47-5

Purchase 1258597-47-5

Order 1258597-47-5

Enquire 1258597-47-5

price of 1258597-47-5

1258597-47-5 Supplier

1258597-47-5 Manufacturer

1258597-47-5 Exporter

buy high quality Apremilast D5

Purchase Apremilast D5

Apremilast D5 suppliers

Apremilast D5 manufacturers

Apremilast D5 price

Order Apremilast D5

Enquire Apremilast D5

Apremilast D5 cost

Apremilast D5 Supplier

Apremilast D5 Distributor

Apremilast D5 for Method Validation

Apremilast Reference Standard

Apremilast D5 for ANDA Filing

Apremilast D5 for Forced Degradation Studies

Apremilast D5 Identification Standards

Apremilast D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,